JP2013512938A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013512938A5 JP2013512938A5 JP2012542475A JP2012542475A JP2013512938A5 JP 2013512938 A5 JP2013512938 A5 JP 2013512938A5 JP 2012542475 A JP2012542475 A JP 2012542475A JP 2012542475 A JP2012542475 A JP 2012542475A JP 2013512938 A5 JP2013512938 A5 JP 2013512938A5
- Authority
- JP
- Japan
- Prior art keywords
- salt
- sucrose octasulfate
- compound
- zinc salt
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 8
- 239000011701 zinc Substances 0.000 claims 7
- 238000000034 method Methods 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 150000003751 zinc Chemical class 0.000 claims 5
- -1 sucrose octasulfate ester salt Chemical class 0.000 claims 4
- 206010052428 Wound Diseases 0.000 claims 3
- 208000027418 Wounds and injury Diseases 0.000 claims 3
- 231100000241 scar Toxicity 0.000 claims 3
- 208000032544 Cicatrix Diseases 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- 230000035876 healing Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 210000004400 mucous membrane Anatomy 0.000 claims 2
- 230000001376 precipitating effect Effects 0.000 claims 2
- 230000037387 scars Effects 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 206010012444 Dermatitis diaper Diseases 0.000 claims 1
- 208000003105 Diaper Rash Diseases 0.000 claims 1
- 208000010201 Exanthema Diseases 0.000 claims 1
- 208000005230 Leg Ulcer Diseases 0.000 claims 1
- 208000004210 Pressure Ulcer Diseases 0.000 claims 1
- 208000007107 Stomach Ulcer Diseases 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 208000007287 cheilitis Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 230000003628 erosive effect Effects 0.000 claims 1
- 201000005884 exanthem Diseases 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- 238000007710 freezing Methods 0.000 claims 1
- 238000005342 ion exchange Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- XISWAUUBQBEDFB-QRDGSJRXSA-F octapotassium;[(2r,3r,4s,5r,6r)-2-[(2s,3s,4r,5r)-3,4-disulfonatooxy-2,5-bis(sulfonatooxymethyl)oxolan-2-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)oxan-4-yl] sulfate Chemical group [K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[O-]S(=O)(=O)O[C@H]1[C@H](OS([O-])(=O)=O)[C@@H](COS(=O)(=O)[O-])O[C@@]1(COS([O-])(=O)=O)O[C@@H]1[C@H](OS([O-])(=O)=O)[C@@H](OS([O-])(=O)=O)[C@H](OS([O-])(=O)=O)[C@@H](COS([O-])(=O)=O)O1 XISWAUUBQBEDFB-QRDGSJRXSA-F 0.000 claims 1
- CPRSOZZDECJZKH-QRDGSJRXSA-F octasodium;[(2r,3r,4s,5r,6r)-2-[(2s,3s,4r,5r)-3,4-disulfonatooxy-2,5-bis(sulfonatooxymethyl)oxolan-2-yl]oxy-3,5-disulfonatooxy-6-(sulfonatooxymethyl)oxan-4-yl] sulfate Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[O-]S(=O)(=O)O[C@H]1[C@H](OS([O-])(=O)=O)[C@@H](COS(=O)(=O)[O-])O[C@@]1(COS([O-])(=O)=O)O[C@@H]1[C@H](OS([O-])(=O)=O)[C@@H](OS([O-])(=O)=O)[C@H](OS([O-])(=O)=O)[C@@H](COS([O-])(=O)=O)O1 CPRSOZZDECJZKH-QRDGSJRXSA-F 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 claims 1
- 208000006934 radiodermatitis Diseases 0.000 claims 1
- 206010037844 rash Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- WEPNHBQBLCNOBB-FZJVNAOYSA-N sucrose octasulfate Chemical class OS(=O)(=O)O[C@@H]1[C@H](OS(O)(=O)=O)[C@H](COS(=O)(=O)O)O[C@]1(COS(O)(=O)=O)O[C@@H]1[C@H](OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@@H](COS(O)(=O)=O)O1 WEPNHBQBLCNOBB-FZJVNAOYSA-N 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000029663 wound healing Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0958689A FR2953522B1 (fr) | 2009-12-07 | 2009-12-07 | Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques |
| FR0958689 | 2009-12-07 | ||
| PCT/EP2010/068873 WO2011069921A1 (fr) | 2009-12-07 | 2010-12-03 | Sucrose octasulfates de zinc, leur preparation et leurs applications pharmaceutiques et cosmetiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013512938A JP2013512938A (ja) | 2013-04-18 |
| JP2013512938A5 true JP2013512938A5 (cg-RX-API-DMAC7.html) | 2014-01-23 |
Family
ID=42044412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012542475A Pending JP2013512938A (ja) | 2009-12-07 | 2010-12-03 | ショ糖オクタ硫酸エステル亜鉛塩、それらの製造、ならびにその医薬品および化粧品用途 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20120245120A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2509989A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2013512938A (cg-RX-API-DMAC7.html) |
| AR (1) | AR079312A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2953522B1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW201127388A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011069921A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2977798B1 (fr) | 2011-07-13 | 2016-07-29 | Urgo Lab | Utilisation de composes oligosaccharidiques pour la prevention et le traitement des cicatrices pathologiques |
| FR2977797B1 (fr) * | 2011-07-13 | 2014-01-17 | Urgo Lab | Utilisation cosmetique et/ou dermatologique de composes oligosaccharidiques pour la prevention et le traitement des vergetures |
| BR112014015245A8 (pt) * | 2011-12-21 | 2017-07-04 | Colgate Palmolive Co | métodos e produtos para diagnosticar e tratar doença de calor |
| FR2991876B1 (fr) | 2012-06-13 | 2014-11-21 | Vivacy Lab | Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate |
| FR2993182B1 (fr) | 2012-07-13 | 2014-10-17 | Urgo Lab | Pansement a liberation prolongee d'actifs |
| CN103193835B (zh) * | 2013-04-18 | 2015-06-24 | 安徽赛诺制药有限公司 | 一种蔗糖八磺酸酯钠合成及纯化的方法 |
| CN114436858A (zh) * | 2020-11-03 | 2022-05-06 | 江苏开元药业有限公司 | 一种药用辅料的三乙胺盐的制备方法 |
| CN116063360A (zh) * | 2022-09-22 | 2023-05-05 | 麦吉丽生物科技有限公司 | 用于改善皮肤功能的二糖聚硫酸盐及其制备方法和用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1390007A (fr) | 1964-04-13 | 1965-02-19 | Plage permettant d'intégrer sur un disque un enregistrement publicitaire ou autre | |
| AU607690B2 (en) | 1985-12-24 | 1991-03-14 | Marion Laboratories, Inc. | Use of synthetic sulfated saccharides to enhance wound healing |
| ZA869530B (en) * | 1985-12-24 | 1987-10-28 | Marion Laboratories Inc | Use of synthetic sulfated saccharides to enhance wound healing |
| DK505488D0 (da) * | 1987-12-21 | 1988-09-09 | Bar Shalom Daniel | Middel og anvendelse af samme |
| US5908836A (en) * | 1987-12-21 | 1999-06-01 | Bar-Shalom; Daniel | Protecting skin from radiation damage using sulphated sugars |
| US5618798A (en) | 1989-04-20 | 1997-04-08 | Bar-Shalom; Daniel | Use of sucralfate to treat baldness |
| DK191889D0 (da) * | 1989-04-20 | 1989-04-20 | Bukh Meditec | Kosmetisk middel |
| FR2646604B1 (fr) | 1989-05-03 | 1994-02-04 | Fabre Medicament Pierre | Composition pour usage externe a base de sucralfate et son procede de preparation |
| DK86492D0 (da) | 1992-06-30 | 1992-06-30 | Bukh Meditec | Laegemiddel |
| US20090215717A1 (en) * | 2004-08-05 | 2009-08-27 | Ivax Drug Research Institute Ltd. | Sulfated oligosaccharides |
| FR2916355B1 (fr) * | 2007-05-25 | 2009-08-28 | Urgo Soc Par Actions Simplifie | Nouveau principe actif dans la cicatrisation et son utilisation |
-
2009
- 2009-12-07 FR FR0958689A patent/FR2953522B1/fr not_active Expired - Fee Related
-
2010
- 2010-12-03 WO PCT/EP2010/068873 patent/WO2011069921A1/fr not_active Ceased
- 2010-12-03 EP EP10795975A patent/EP2509989A1/fr not_active Withdrawn
- 2010-12-03 JP JP2012542475A patent/JP2013512938A/ja active Pending
- 2010-12-03 US US13/514,121 patent/US20120245120A1/en not_active Abandoned
- 2010-12-06 TW TW099142344A patent/TW201127388A/zh unknown
- 2010-12-07 AR ARP100104511A patent/AR079312A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013512938A5 (cg-RX-API-DMAC7.html) | ||
| KR20240039083A (ko) | 약제학적 제형 | |
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| WO2014153238A9 (en) | Compositions, methods and devices for promoting wound healing and reducing infection | |
| JP2010270124A5 (cg-RX-API-DMAC7.html) | ||
| JP2017518302A5 (cg-RX-API-DMAC7.html) | ||
| RU2014110399A (ru) | Кристаллические формы вгс протеазного ингибитора | |
| WO2012083122A8 (en) | Inhibitors of influenza viruses replication | |
| RU2017127273A (ru) | Короткие антимикробные липопептиды | |
| JP2015522589A5 (cg-RX-API-DMAC7.html) | ||
| RU2012156266A (ru) | Новая синергическая фармацевтическая композиция для топического нанесения | |
| MX2011009709A (es) | Compuestos para el tratamiento de la inflamacion y del dolor. | |
| RU2015102772A (ru) | Бензодиазелипы для мелкоклеточного рака легкого | |
| WO2011112875A3 (en) | Foamable formulation | |
| JP2015509075A5 (cg-RX-API-DMAC7.html) | ||
| JP2017514866A5 (cg-RX-API-DMAC7.html) | ||
| JP2012508256A5 (cg-RX-API-DMAC7.html) | ||
| CA2647346A1 (en) | Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid | |
| TN2014000031A1 (en) | Use of organic compound for the treatment of noonan syndrome | |
| CA2796412A1 (en) | Method for treating scars with adapalene 0.3% | |
| KR101654028B1 (ko) | 피부 도포용 화장료 조성물 및 이의 제조방법 | |
| JP2014509637A5 (cg-RX-API-DMAC7.html) | ||
| CN105920589A (zh) | 医用射线防护喷剂及其生产工艺 | |
| JP2015526499A5 (cg-RX-API-DMAC7.html) | ||
| JP2014515388A5 (cg-RX-API-DMAC7.html) |